The U.S. Nourishment and Drug Administration has asked the
organization Endo Pharmaceuticals to expel one of its medications from the
market due to its high potential for manhandle.
Opana E-R is a capable painkiller that the organization says
is being pounded up and infused by individuals looking to mishandle it.
This is the first run through the FDA has made such move,
however they say the dangers of the medication exceed the advantages.
Endo Pharmaceuticals says the medication is protected and
compelling.
The organization discharged an announcement saying they are
"checking on the demand" and they are "assessing the full scope
of potential alternatives" to "decide the suitable way ahead."
Tags
Top News